Unknown

Dataset Information

0

An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections.

ABSTRACT: Powassan virus (POWV) is an emerging tick-transmitted flavivirus that circulates in North America and Russia. Up to 5% of deer ticks now test positive for POWV in certain regions of the northern United States. Although POWV infections cause life-threatening encephalitis, there is no vaccine or countermeasure available for prevention or treatment. Here, we developed a lipid nanoparticle (LNP)-encapsulated modified mRNA vaccine encoding the POWV prM and E genes and demonstrated its immunogenicity and efficacy in mice following immunization with one or two doses. The POWV mRNA vaccine induced high titers of neutralizing antibody and sterilizing immunity against lethal challenge with different POWV strains. The mRNA vaccine also induced cross-neutralizing antibodies against multiple other tick-borne flaviviruses and protected mice against the distantly related Langat virus. These data demonstrate the utility of the LNP-mRNA vaccine platform for the development of vaccines with protective activity against multiple flaviviruses.

SUBMITTER: VanBlargan LA 

PROVIDER: S-EPMC6353567 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections.

VanBlargan Laura A LA   Himansu Sunny S   Foreman Bryant M BM   Ebel Gregory D GD   Pierson Theodore C TC   Diamond Michael S MS  

Cell reports 20181201 12

Powassan virus (POWV) is an emerging tick-transmitted flavivirus that circulates in North America and Russia. Up to 5% of deer ticks now test positive for POWV in certain regions of the northern United States. Although POWV infections cause life-threatening encephalitis, there is no vaccine or countermeasure available for prevention or treatment. Here, we developed a lipid nanoparticle (LNP)-encapsulated modified mRNA vaccine encoding the POWV prM and E genes and demonstrated its immunogenicity  ...[more]

Similar Datasets

Unknown mRNA Vaccine Protects against Zika Virus.
| S-EPMC8707647 | biostudies-literature
Unknown RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge.
| S-EPMC9045870 | biostudies-literature
Unknown A taRNA vaccine candidate induces a specific immune response that protects mice against Chikungunya virus infections.
| S-EPMC9126847 | biostudies-literature
Unknown Intranasal vaccine for Lyme disease provides protection against tick transmitted Borrelia burgdorferi beyond one year.
| S-EPMC10869809 | biostudies-literature
Unknown Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus Infections.
| S-EPMC5908250 | biostudies-literature
Unknown Construction and characterization of a single-cycle chimeric flavivirus vaccine candidate that protects mice against lethal challenge with dengue virus type 2.
| S-EPMC2643768 | biostudies-literature
Unknown The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300.
| S-EPMC2657196 | biostudies-literature
Unknown Immunization with an mRNA DTP vaccine protects against pertussis in rats.
| S-EPMC11320933 | biostudies-literature
Unknown PEDV-spike-protein-expressing mRNA vaccine protects piglets against PEDV challenge.
| S-EPMC10865985 | biostudies-literature
Unknown Infectious RNA vaccine protects mice against chikungunya virus infection.
| S-EPMC7712826 | biostudies-literature